Exact Mass: 290.1185834
Exact Mass Matches: 290.1185834
Found 391 metabolites which its exact mass value is equals to given mass value 290.1185834,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5-O-Methylvisamminol
5-O-Methylvisamminol is an oxacycle and an organic heterotricyclic compound. 5-O-Methylvisamminol is a natural product found in Saposhnikovia divaricata, Angelica japonica, and Prionosciadium thapsoides with data available. 5-O-Methylvisamminol, a (furo) chromone identified in the extract of T. glauca, has a limited occurrence in the plant kingdom. 5-O-Methylvisamminol is useful in (chemical) phylogeny and is a possible excellent chemotaxonomic marker (family and/or subfamily level) for Apiaceae[1]. 5-O-Methylvisamminol, a (furo) chromone identified in the extract of T. glauca, has a limited occurrence in the plant kingdom. 5-O-Methylvisamminol is useful in (chemical) phylogeny and is a possible excellent chemotaxonomic marker (family and/or subfamily level) for Apiaceae[1].
Argininosuccinic acid disodium
C10H18N4O6 (290.12262880000003)
Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the argininosuccinate lyase enzyme can lead to argininosuccinate lyase deficiency, which is an inborn error of metabolism. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (argininosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema. Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the arginosuccinate lyase enzyme can lead to arginosuccinate lyase deficiency. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (arginosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema. [HMDB] KEIO_ID A039; [MS2] KO008844 KEIO_ID A039
Carbinoxamine
Carbinoxamine, also known as carbinoxamine maleate or clistin, is a member of the class of compounds known as benzylethers. Benzylethers are aromatic ethers with the general formula ROCR (R = alkyl, aryl; R=benzene). Carbinoxamine is practically insoluble (in water) and a very strong basic compound (based on its pKa). Carbinoxamine can be found in barley and garden onion, which makes carbinoxamine a potential biomarker for the consumption of these food products. Carbinoxamine can be found primarily in blood and urine. In humans, carbinoxamine is involved in the carbinoxamine h1-antihistamine action. Carbinoxamine is a non-carcinogenic (not listed by IARC) potentially toxic compound. Carbinoxamine is a drug which is used for symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis, as well as allergic conjunctivitis caused by foods and inhaled allergens. also for the relief of allergic reactions to blood or plasma, and the symptomatic management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Carbinoxamine (Clistin, Palgic, Rondec, Rhinopront) is a antihistamine and anticholinergic agent. It was first launched in the United States by the McNeil Corporation under the brand name Clistin. It is now available under the brand name Palgic as 4 mg tablets or 4 mg/5 mL liquid. It is approved by the U.S. Food and Drug Administration (FDA) (specifically at the 4 mg dose/strength) for hay fever (a.k.a. allergic rhinitis, SAR and PAR); vasomotor rhinitis; mild urticaria; angioedema, dermatographism and allergic conjunctivitis. Carbinoxamine is a histamine antagonist, specifically an H1-antagonist. The maleic acid salt of the levorotatory isomer is sold as the prescription drug rotoxamine . Carbinoxamine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. Carbinoxamines anticholinergic action appears to be due to a central antimuscarinic effect, which also may be responsible for its antiemetic effects, although the exact mechanism is unknown (DrugBank). Carbinoxamine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. Carbinoxamines anticholinergic action appears to be due to a central antimuscarinic effect, which also may be responsible for its antiemetic effects, although the exact mechanism is unknown (T3DB). Carbinoxamine is a first generation antihistamine that competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. The product label for carbinoxamine as an over the counter cough and cold medicine is being modified to state do not use in children under 4 years of age in order to prevent and reduce misuse, as many unapproved carbinoxamine-containing preparations contained inappropriate labeling, which promoted unapproved uses (including management of congestion, cough, the common cold, and the use in children under 2 years of age), which can potentially cause serious health risks. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
N-Succinyl-L,L-2,6-diaminopimelate
C11H18N2O7 (290.11139579999997)
N-Succinyl-L,L-2,6-diaminopimelate is an intermediate in lysine biosynthesis. It is the third to last step in the synthesis of lysine and is converted. from N-Succinyl-2-amino-6-ketopimelate via the enzyme succinyldiaminopimelate transferase (EC 2.6.1.17). It is then converted to L,L-diaminopimelate via the enzyme succinyl-diaminopimelate desuccinylase (EC 3.5.1.18). N-Succinyl-L,L-2,6-diaminopimelate is an intermediate in lysine biosynthesis. It is the third to last step in the synthesis of lysine and is converted
N2-(3-Carboxy-2-hydroxy-1-oxopropyl)arginine
C10H18N4O6 (290.12262880000003)
N2-(3-Carboxy-2-hydroxy-1-oxopropyl)arginine is found in pomes. N2-(3-Carboxy-2-hydroxy-1-oxopropyl)arginine is a constituent of the seeds of Vicia faba and the shoots of apple and pear trees. Constituent of the seeds of Vicia faba and the shoots of apple and pear trees. N2-(3-Carboxy-2-hydroxy-1-oxopropyl)arginine is found in pomes and pulses.
5,6-Dihydro-11-methoxyyangonin
5,6-Dihydro-11-methoxyyangonin is found in beverages. 5,6-Dihydro-11-methoxyyangonin is isolated from Piper methysticum (kava). FDA advises against use of kava in food due to potential risk of severe liver damage (2002). Isolated from Piper methysticum (kava). FDA advises against use of kava in food due to potential risk of severe liver damage (2002). 5,6-Dihydro-11-methoxyyangonin is found in beverages.
N2-(3-Hydroxysuccinoyl)arginine
C10H18N4O6 (290.12262880000003)
N2-(3-Hydroxysuccinoyl)arginine is found in pomes. N2-(3-Hydroxysuccinoyl)arginine is a constituent of the shoots of apple and pear trees. Constituent of the shoots of apple and pear trees. N2-(3-Hydroxysuccinoyl)arginine is found in pomes.
ARGININOSUCCINATE
C10H18N4O6 (290.12262880000003)
Glycine, N-[1-(phenylacetyl)-L-prolyl]-
Dehydrocurvularin
D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Toddanone
5,7-Dimethoxy-6-(3-methyl-2-oxobutyl)chromen-2-one is a natural product found in Zanthoxylum asiaticum with data available.
2-(Acetyloxy)-1-(7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-ethanone
3-[2-(3,4,5-trimethoxyphenyl)ethenyl]-4,5-dihydro-1H-pyridazin-6-one
1-(4-Hydroxyphenyl)-2-(3-methoxy-4-hydroxyphenyl)propane-1,3-diol
(1E)-5,7-dimethoxy-8-(3-hydroxy-3-methylbut-1-enyl)coumarin|(E)-8-(3-hydroxy-3-methyl-1-butenyl)-5,7-dimethoxycoumarin|5,7-dimethoxy-8-((E)-3-hydroxy-3-methylbut-1-enyl)coumarin|5-methoxymurraol
(2E,6E)-8-(2,5-dihydroxyphenyl)-2,6-dimethyl-8-oxo-2,6-octadienoic acid|orirubenone D
(S)-3,4,4-trihydroxy-5,alpha-dimethoxybibenzyl|dendrocandin C
8beta-methoxyeremophil-3,7(11)-diene-8alpha,12(6alpha,15)-diolide
8-hydroxy-6,7-dimethoxy-3-(2-methylbut-3-en-2-yl)-2H-chromen-2-one|barbatumol A
7-hydroxy-6,8-dimethoxy-3-(2-methylbut-3-en-2-yl)-2H-chromen-2-one|barbatumol B
2S-isopropenyl-4,8-dimethoxy-5-hydroxy-6-methyl-2,3-dihydrobenzo[1,2-b;5,4-b]difuran
1-(2-hydroxy-4-methoxyphenyl)-3-(4-hydroxyphenyl)propane-1,2-diol|peapolyphenol B
2,2-dimethyl-4-oxo-8-(2-oxopropyl)-chroman-6-yl acetate
Dihydroageraton-O-methylaether|Dihydroageratone -6-Me ether
3-(4-acetoxyprenyl)-7E-p-coumaric acid|3-<4-acetoxyprenyl>-7E-p-coumaric acid
4-[2-(5-Hydroxy-1H-indole-3-yl)ethylamino]-4-oxobutyric acid methyl ester
(R)-4,5-dimethoxy-3-(4-phenyl-2-oxobutyl)-5H-furan-2-one|fissohamione
chrysopine
C11H18N2O7 (290.11139579999997)
A spiroketal and delta-lactone resulting from the formal condensation of the carboxy group of L-glutamine with the anomeric hydroxy group of D-fructose and substitution of the 1-hydroxy group of the fructose by the alpha-amino group of the glutamine. It is found in crown gall tumours induced in chrysanthemums by Agrobacterium tumefaciens.
(3S,8S)-cordiarimide B|cordiarimide B|N-[(S)-1-[(S)-2-hydroxy-2-phenylethyl]-2,6-dioxopiperidin-3-yl]acetamide
15-Aldehyde,Me ester-(1(10)E,4E,6alpha)-15-Hydroxy-1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid|Methyl 15-oxogermacra-1(10)E,4E,11(13)-trien-6alpha,12-olide-14-oic acid
n-(6-hydroxyindol-3-ylacetyl)-valine
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
Toddanol
(-)-Toddanol is a natural product found in Zanthoxylum asiaticum with data available.
Artain
Artanin is a natural product found in Artemisia tanacetifolia and Artemisia atrata with data available.
8-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxychromen-2-one
8-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxychromen-2-one
C16H18O5_(8E)-11,13-Dihydroxy-4-methyl-4,5,6,7-tetrahydro-2H-3-benzoxacyclododecine-2,10(1H)-dione
8-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxychromen-2-one
Argininosuccinic acid
C10H18N4O6 (290.12262880000003)
MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; KDZOASGQNOPSCU_STSL_0151_Argininosuccinic acid_8000fmol_180506_S2_LC02_MS02_235; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.
8-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxychromen-2-one_major
Ala Gly Gly Ser
C10H18N4O6 (290.12262880000003)
Ala Gly Ser Gly
C10H18N4O6 (290.12262880000003)
Ala Ser Gly Gly
C10H18N4O6 (290.12262880000003)
Gly Ala Gly Ser
C10H18N4O6 (290.12262880000003)
Gly Ala Ser Gly
C10H18N4O6 (290.12262880000003)
Gly Gly Ala Ser
C10H18N4O6 (290.12262880000003)
Gly Gly Gly Thr
C10H18N4O6 (290.12262880000003)
Gly Gly Ser Ala
C10H18N4O6 (290.12262880000003)
Gly Gly Thr Gly
C10H18N4O6 (290.12262880000003)
Gly Ser Ala Gly
C10H18N4O6 (290.12262880000003)
Gly Ser Gly Ala
C10H18N4O6 (290.12262880000003)
Gly Thr Gly Gly
C10H18N4O6 (290.12262880000003)
Ser Ala Gly Gly
C10H18N4O6 (290.12262880000003)
Ser Gly Ala Gly
C10H18N4O6 (290.12262880000003)
Ser Gly Gly Ala
C10H18N4O6 (290.12262880000003)
Thr Gly Gly Gly
C10H18N4O6 (290.12262880000003)
N2-(3-Hydroxysuccinoyl)arginine
C10H18N4O6 (290.12262880000003)
5,6-Dihydro-11-methoxyyangonin
N2-(2-Hydroxysuccinoyl)arginine
C10H18N4O6 (290.12262880000003)
1-(1-phenylmethoxycarbonylazetidin-3-yl)azetidine-3-carboxylic acid
2-[2-fluoro-5-(trifluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
ethyl 1-(aminomethyl)-6,8-dimethoxyisoquinoline-4-carboxylate
4-Hydroxy-8-isopropyl-6,7-dimethoxy-2-naphthoic acid
4-Amino-2-deoxy-2,3-dehydro-n-neuraminic acid
C11H18N2O7 (290.11139579999997)
N4-(3-ETHYNYLPHENYL)-7-METHOXYQUINAZOLINE-4,6-DIAMINE
1-TERT-BUTYL 5-METHYL 3-METHYL-1H-INDAZOLE-1,5-DICARBOXYLATE
4-ETHYL-2-(2-ETHYL-PYRIDIN-4-YL)-THIAZOLE-5-CARBOXYLIC ACID ETHYL ESTER
C15H18N2O2S (290.10889280000004)
4-((4-((TRIMETHYLSILYL)ETHYNYL)PHENYL)ETHYNYL)PHENOL
2-Fluoro-3-(trifluoromethyl)phenylboronic acid pinacol ester
Ethyl 4-hydroxy-1-isopropyl-7-methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate
ETHYL 4-HYDROXY-7-METHYL-2-OXO-1-PROPYL-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYLATE
TERT-BUTYL (2-AMINO-4-(THIOPHEN-2-YL)PHENYL)CARBAMATE
C15H18N2O2S (290.10889280000004)
2-Cyclopropyl-7,8-dimethoxy-2H-chromene-5-carboxylic acid methyl ester
5-Amino-N-ethyl-2-methyl-N-phenylbenzenesulphonamide
C15H18N2O2S (290.10889280000004)
N-((1R,2R)-2-AMINO-1,2-DIPHENYLETHYL)METHANESULFONAMIDE
C15H18N2O2S (290.10889280000004)
1-(2-HYDROXY-2-METHYLPROPYL)-5-METHYL-3-OXO-2-PHENYL-2,3-DIHYDROPYRAZOLE-4-CARBOXYLIC ACID
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-thienylmethyl)-1H-pyrazole
2-TERT-BUTOXYCARBONYLAMINO-3-(4-CYANO-PHENYL)-PROPIONIC ACID
1,2-o-isopropylidene-3-benzoyloxy-5,6-dideoxy-glucofuranose
Diethyl 2,6-dimethyl-1H-pyrrolo[2,3-b]pyridine-3,5-dicarboxylate
3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine oxide
1-CYANO-2-ETHOXYCARBONYL-6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE
1-PHENYL-2-PYRROLIDIN-1-YL-ETHYLAMINE
C15H18N2O2S (290.10889280000004)
2-(2-Fluoro-4-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
4-Fluoro-3-(trifluoroMethyl)phenylboronic acid pinacol ester
2-(3-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
N-(4-Aminobenzyl)-N-methyl-p-Toluenesulfonamide
C15H18N2O2S (290.10889280000004)
9-Amino-2-deoxy-2,3-dehydro-n-acetyl-neuraminic acid
C11H18N2O7 (290.11139579999997)
N-[(4-methyl-5-phenyldiazenyl-2-imidazolylidene)amino]aniline
Ethyl 5-methyl-2-[(2-phenylethyl)amino]-1,3-thiazole-4-carboxylate
C15H18N2O2S (290.10889280000004)
(2R)-2-[[N-[(4S)-4-amino-4-carboxybutyl]carbamimidoyl]amino]butanedioic acid
C10H18N4O6 (290.12262880000003)
3-Hydroxymethyl-5-aziridinyl-1methyl-2-[1h-indole-4,7-dione]-propanol
80681-42-1
5-O-Methylvisamminol, a (furo) chromone identified in the extract of T. glauca, has a limited occurrence in the plant kingdom. 5-O-Methylvisamminol is useful in (chemical) phylogeny and is a possible excellent chemotaxonomic marker (family and/or subfamily level) for Apiaceae[1]. 5-O-Methylvisamminol, a (furo) chromone identified in the extract of T. glauca, has a limited occurrence in the plant kingdom. 5-O-Methylvisamminol is useful in (chemical) phylogeny and is a possible excellent chemotaxonomic marker (family and/or subfamily level) for Apiaceae[1].
2-Hydroxy-3-methoxy-6-methyl-5,8-dioxo-4-propan-2-yl-6,7-dihydronaphthalene-1-carbaldehyde
2-[[2-(6-Hydroxy-1H-indol-3-yl)acetyl]amino]-3-methylbutanoic acid
(2S)-3-methyl-2-[[2-(2-oxo-1,3-dihydroindol-3-yl)acetyl]amino]butanoic acid
Dendrocandin C
A diphenylethane that is 1,2-dihydrostilbene substituted by hydroxy groups at positions 3, 4 and 4 and methoxy groups at C-5 and alpha-position respectively (the S stereoisomer). It is isolated from the stems of Dendrobium candidum and exhibits antioxidant activity.
1-[4-Methyl-2-[2-(4-methylphenoxy)ethylamino]-5-thiazolyl]ethanone
C15H18N2O2S (290.10889280000004)
N-(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)-2-oxolanecarboxamide
C15H18N2O2S (290.10889280000004)
3-chloro-N-methyl-N-[4-(1-pyrrolidinyl)but-2-ynyl]benzamide
4-amino-N-[(1E)-(3,4-dimethoxyphenyl)methylene]-1,2,5-oxadiazole-3-carbohydrazonamide
2S-Isopropenyl-4,8-dimethoxy-5-hydroxy-6-methyl-2,3-dihydrobenzo[1,2-b:5,4-b]difuran
A natural product found in Cyperus teneriffae.
2,6-Dimethyl-4-(1-phenyl-4-pyrazolyl)furo[2,3-d]pyrimidine
N-[(3-ethoxy-2-prop-2-enoxyphenyl)methyl]-2-thiazolamine
C15H18N2O2S (290.10889280000004)
1-(2,3-Dimethyl-6-quinoxalinyl)-3-(3-hydroxypropyl)thiourea
C14H18N4OS (290.12012580000004)
ethyl 3-amino-7,7-dimethyl-7,8-dihydro-5H-furo[2,3-b]pyrano[3,4-e]pyridine-2-carboxylate
tert-butyl N-[(E)-[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enylidene]amino]carbamate
beta-Chrysopine
C11H18N2O7 (290.11139579999997)
A chrysopine formally derived from beta-D-fructopyranose.
alpha-Chrysopine
C11H18N2O7 (290.11139579999997)
A chrysopine formally derived from alpha-D-fructopyranose.
(9Z)-13,15-dihydroxy-5-methyl-4-oxabicyclo[10.4.0]hexadeca-1(12),9,13,15-tetraene-3,11-dione
2-(3-Chloropropionyl)-5,7-dimethyl-1,2,3,4-tetrahydropyrimido(1,6-A)indole
2-[(Z)-2,4-Hexadiynylidene]-3-acetoxy-1,6-dioxaspiro[4.5]decan-4-ol
carbinoxamine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
N-succinyl-LL-2,6-diaminopimelic acid
C11H18N2O7 (290.11139579999997)
A tricarboxylic acid consisting of LL-2,6-diaminopimelic acid having a succinoyl group attached to one of the nitrogens.
(N(omega)-L-arginino)succinic acid
C10H18N4O6 (290.12262880000003)
N-Succinyl-L,L-2,6-diaminopimelate
C11H18N2O7 (290.11139579999997)
N2-(3-Carboxy-2-hydroxy-1-oxopropyl)arginine
C10H18N4O6 (290.12262880000003)
alpha,beta-Dehydrocurvularin
D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
11,13-dihydroxy-4-methyl-2,4,5,6,7,10-hexahydro-1H-3-benzoxacyclododecine-2,10-dione
2-naphthyl alpha-L-fucoside
An alpha-L-fucoside that is alpha-L-fucopyranose in which the anomeric hydroxy hydrogen is replaced by a 2-naphthyl group.
4,5,4-trihydroxy-3,3-dimethoxybibenzyl
A diphenylethane that is 1,2-dihydrostilbene substituted by hydroxy groups at positions 4, 4, and 5 and a methoxy groups at positions 3 and 3. It is isolated from Dendrobium ellipsophyllum and sensitizes lung cancer cells to anoikis.
M4 mAChR agonist-1
C14H18N4OS (290.12012580000004)
M4 mAChR agonist-1 (compound 10a) is a potent M4 mAChR agonist with an EC50 >10 μM for human M4[1].
4-[(1s)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propyl]benzene-1,3-diol
2-[(2r)-5-acetyl-6-methoxy-2,3-dihydro-1-benzofuran-2-yl]prop-2-en-1-yl acetate
(7s,8r)-5-ethyl-8,11-dihydroxy-12-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one
6-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-5,7-dimethoxychromen-2-one
2,8-dihydroxy-6-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroxanthen-9-one
(2s,3s)-2-[(1r,6s,7r,8s)-8-methyl-9-oxabicyclo[4.2.1]nona-2,4-dien-7-yl]-6-oxo-2,3-dihydropyran-3-yl acetate
5,8-dihydroxy-2-(4-hydroxy-4-methylpentyl)naphthalene-1,4-dione
(3s,5r)-3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one
(3r)-12,14-dihydroxy-3-methyl-4,5,6,10-tetrahydro-3h-2-benzoxacyclododecine-1,9-dione
5-hydroxy-8-[(1s)-1-hydroxy-3-methylbut-3-en-1-yl]-7-methoxy-2-methylchromen-4-one
(5r)-5-(2,5-dihydroxyphenyl)-3-(5-hydroxy-4-methylpent-3-en-1-yl)-5h-furan-2-one
2-(5-acetyl-6-methoxy-2,3-dihydro-1-benzofuran-2-yl)prop-2-en-1-yl acetate
13-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
6-[2-(3,4-dimethoxyphenyl)ethenyl]-4-methoxy-5,6-dihydropyran-2-one
6-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-5,7-dimethoxychromen-2-one
3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one
11-methoxy-5,6-dihydroyangonin
{"Ingredient_id": "HBIN000465","Ingredient_name": "11-methoxy-5,6-dihydroyangonin","Alias": "NA","Ingredient_formula": "C16H18O5","Ingredient_Smile": "COC1=CC(=O)OC(C1)C=CC2=CC(=C(C=C2)OC)OC","Ingredient_weight": "290.31 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13908","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "636590","DrugBank_id": "NA"}
12-acetoxyfraxinellon
{"Ingredient_id": "HBIN000696","Ingredient_name": "12-acetoxyfraxinellon","Alias": "NA","Ingredient_formula": "C16H18O5","Ingredient_Smile": "NA","Ingredient_weight": "290.315","OB_score": "NA","CAS_id": "220210-99-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9370","PubChem_id": "NA","DrugBank_id": "NA"}
5,6-dimethoxy-8-(3'-methyl-2'-oxobutyl)coumarin
{"Ingredient_id": "HBIN011143","Ingredient_name": "5,6-dimethoxy-8-(3'-methyl-2'-oxobutyl)coumarin","Alias": "NA","Ingredient_formula": "C16H18O5","Ingredient_Smile": "CC(C)C(=O)CC1=CC(=C(C2=C1OC(=O)C=C2)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25852","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7-dimethoxy-8-(2'-oxo-3'-methylbutyl)coumarin
{"Ingredient_id": "HBIN011315","Ingredient_name": "5,7-dimethoxy-8-(2'-oxo-3'-methylbutyl)coumarin","Alias": "NA","Ingredient_formula": "C16H18O5","Ingredient_Smile": "CC(C)C(=O)CC1=C(C=C(C2=C1OC(=O)C=C2)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25851","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-methoxy-8-(1'-methoxy-2'-hydroxy-3'-methyl-3'-butenyl)coumarin
{"Ingredient_id": "HBIN013322","Ingredient_name": "7-methoxy-8-(1'-methoxy-2'-hydroxy-3'-methyl-3'-butenyl)coumarin","Alias": "NA","Ingredient_formula": "C16H18O5","Ingredient_Smile": "CC(C)(C=CC1=C(C=C(C2=C1OC(=O)C=C2)OC)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31559","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
albiflorin-2
{"Ingredient_id": "HBIN015076","Ingredient_name": "albiflorin-2","Alias": "NA","Ingredient_formula": "C16H18O5","Ingredient_Smile": "CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "859","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5,7-dimethoxychromen-2-one
8-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-5,7-dimethoxychromen-2-one
(4r,8e)-11,13-dihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
(3r,8s)-8,12,14-trihydroxy-3-methyl-3,4,7,8-tetrahydro-2-benzoxacyclododecin-1-one
4-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]benzene-1,2-diol
2-(hydroxymethyl)-5-methoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-4-one
4-[2-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propyl]benzene-1,3-diol
15-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
11,13-dihydroxy-4-methyl-4,5,6,9-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
(1s,9r,12s,14r,16s)-14-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
4-(3-hydroxy-5-methylphenoxy)-2-(2-hydroxyethyl)-6-(hydroxymethyl)phenol
(5r)-4,5-dimethoxy-3-(2-oxo-4-phenylbutyl)-5h-furan-2-one
8-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-5,7-dimethoxychromen-2-one
(4s)-11,13-dihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
5,7-dimethoxy-8-[(3-methylbut-2-en-1-yl)oxy]chromen-2-one
8-[(3,3-dimethyloxiran-2-yl)methyl]-5,7-dimethoxychromen-2-one
8-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-5,7-dimethoxychromen-2-one
(1s,2r,4r,10s,14s,17r)-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
methyl 3-hydroxy-5,9-dimethyl-11-oxo-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6-triene-4-carboxylate
(3r,5r)-3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one
(4r)-4-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-methyl-5,6-dihydro-3h-pyrimidine-4-carboxylic acid
C11H18N2O7 (290.11139579999997)
(1s,9r,12s,14s,16r)-14-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
(2s,6s)-2-amino-6-[(3-carboxy-1-hydroxypropylidene)amino]heptanedioic acid
C11H18N2O7 (290.11139579999997)
(2z)-2-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-6-methylhepta-2,5-dienoic acid
(3r,6r)-3-(2h-1,3-benzodioxol-5-ylmethyl)-6-isopropyl-3,6-dihydropyrazine-2,5-diol
8-(2-hydroxy-3-methylbut-3-en-1-yl)-5,7-dimethoxychromen-2-one
7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4,10-diol
8-(2,5-dihydroxyphenyl)-2,6-dimethyl-8-oxoocta-2,6-dienoic acid
(1r,2r)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-hydroxyphenyl)propane-1,2-diol
2-methylpropyl 2-(7-hydroxy-2-methyl-4-oxochromen-5-yl)acetate
(1s,9r,12s,14s)-14-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
4-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-methyl-5,6-dihydro-3h-pyrimidine-4-carboxylic acid
C11H18N2O7 (290.11139579999997)
n-[(3s)-1-[(2s)-2-hydroxy-2-phenylethyl]-2,6-dioxopiperidin-3-yl]ethanimidic acid
(8e)-11,13-dihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
6-[(3,3-dimethyloxiran-2-yl)methyl]-5,7-dimethoxychromen-2-one
1-[4-(hydroxymethyl)-3,5-dimethylfuran-2-yl]-7-methoxy-1,3-dihydro-2-benzofuran-5-ol
(1s,2s,3s)-2,8-dihydroxy-6-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroxanthen-9-one
(3ar,4r,4as,9as)-8-methyl-3-methylidene-2,5-dioxo-3ah,4h,4ah,6h,7h,9h,9ah-azuleno[6,5-b]furan-4-yl acetate
(3r,5s)-3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one
(1r,8s,10s)-3-(hydroxymethyl)-1,8-dimethyl-5,9,15-trioxatetracyclo[11.2.1.0²,⁶.0⁸,¹⁰]hexadeca-2(6),3,13(16)-trien-14-one
(1s,9r,12s,15r,16r)-15-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
8-[(1r,2s)-2-hydroxy-1-methoxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
(1r,2s,6s,8e,11s)-11-methoxy-8-methyl-3-methylidene-5,14-dioxatricyclo[10.2.1.0²,⁶]pentadeca-8,12(15)-diene-4,13-dione
(2s,3s)-2-(2-hydroxypropan-2-yl)-3-methoxy-9-methyl-2h,3h-furo[3,2-c]chromen-4-one
2-(2-hydroxy-3-methoxy-5-methylphenoxy)-5-methoxy-3-methylphenol
(11s)-2,8-dimethoxy-5-methyl-11-(prop-1-en-2-yl)-4,12-dioxatricyclo[7.3.0.0³,⁷]dodeca-1(9),2,5,7-tetraen-6-ol
(4r)-9-methoxy-4,12,12-trimethyl-5,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2(7),8-triene-6,14-dione
(1s,6r,9r,12s,16r)-6-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
5-hydroxy-8-(2-hydroxy-3-methylbut-3-en-1-yl)-7-methoxy-2-methylchromen-4-one
11-methoxy-8-methyl-3-methylidene-5,14-dioxatricyclo[10.2.1.0²,⁶]pentadeca-8,12(15)-diene-4,13-dione
6-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
[7-hydroxy-4-oxo-2-(pent-1-en-1-yl)-2,3-dihydro-1-benzopyran-5-yl]acetic acid
(1s,9r,12r,13r,16s)-13-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
2,3,8-trihydroxy-4-isopropyl-7-methoxy-6-methylnaphthalene-1-carbaldehyde
6-hydroxy-2-(4-methylpent-3-en-1-yl)-4-oxo-3h-1-benzopyran-2-carboxylic acid
(3s,4s)-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4,10-diol
2-(7-methoxy-2,2-dimethylchromen-6-yl)-2-oxoethyl acetate
14-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
5-hydroxy-7-methoxy-2-methyl-6-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
(5s)-5-(2,5-dihydroxyphenyl)-3-(5-hydroxy-4-methylpent-3-en-1-yl)-5h-furan-2-one
(1s,6r,8s,15r)-6-methoxy-3,15-dimethyl-5,14-dioxatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-2,11-diene-4,13-dione
(4s,7e)-11,13-dihydroxy-4-methyl-4,5,6,9-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
8-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-5-hydroxy-7-methoxy-2-methylchromen-4-one
12,14-dihydroxy-3-methyl-4,5,6,10-tetrahydro-3h-2-benzoxacyclododecine-1,9-dione
(7s,8s)-5-ethyl-8,11-dihydroxy-12-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one
2-(3-hydroxy-5-methylphenoxy)-4,5-dimethoxy-3-methylphenol
(3r,4s)-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4,10-diol
3,6,13-trihydroxy-9-methyl-15-oxatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-2,4,6-trien-10-one
6-(2-hydroxy-3-methylbut-3-en-1-yl)-5,7-dimethoxychromen-2-one
(1r,6s,8r,15s)-6-methoxy-3,15-dimethyl-5,14-dioxatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-2,11-diene-4,13-dione
ethyl (2s,5z)-2-isopropyl-4-oxo-5-(phenylmethylidene)-1,3-dioxolane-2-carboxylate
2-[(2s)-2-hydroxypropyl]-5,7-dimethoxy-3-methylnaphthalene-1,4-dione
methyl (1r,9s)-3-hydroxy-5,9-dimethyl-11-oxo-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6-triene-4-carboxylate
4-[2-(3-hydroxy-4,5-dimethoxyphenyl)ethyl]benzene-1,2-diol
4-[(2r)-2-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propyl]benzene-1,3-diol
methyl 2-[(1e)-2-[4-(formyloxy)phenyl]ethenyl]-4-methyl-3-oxopentanoate
{7-hydroxy-4-oxo-2-[(1e)-pent-1-en-1-yl]-2,3-dihydro-1-benzopyran-5-yl}acetic acid
5-(2,5-dihydroxyphenyl)-3-[(3z)-5-hydroxy-4-methylpent-3-en-1-yl]-5h-furan-2-one
n-[(3s)-1-[(2r)-2-hydroxy-2-phenylethyl]-2,6-dioxopiperidin-3-yl]ethanimidic acid
8-[(3,3-dimethyloxiran-2-yl)methyl]-5-hydroxy-7-methoxy-2-methylchromen-4-one
2-[(2s)-5-acetyl-6-methoxy-2,3-dihydro-1-benzofuran-2-yl]prop-2-en-1-yl acetate
(1r,9s,13s,16r)-3,6,13-trihydroxy-9-methyl-15-oxatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-2,4,6-trien-10-one
(1s)-1-[4-(hydroxymethyl)-3,5-dimethylfuran-2-yl]-7-methoxy-1,3-dihydro-2-benzofuran-5-ol
(2e,6e)-8-(2,5-dihydroxyphenyl)-2,6-dimethyl-8-oxoocta-2,6-dienoic acid
10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
7,8-dimethoxy-5-[(3-methylbut-2-en-1-yl)oxy]chromen-2-one
(3s,7z)-12,14-dihydroxy-3-methyl-4,5,6,10-tetrahydro-3h-2-benzoxacyclododecine-1,9-dione
(5e,7s,8r)-5-ethylidene-8,12-dihydroxy-13-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one
n-[1-(2-hydroxy-2-phenylethyl)-2,6-dioxopiperidin-3-yl]ethanimidic acid
(6r)-6-[(1e)-2-(3,4-dimethoxyphenyl)ethenyl]-4-methoxy-5,6-dihydropyran-2-one
(1r,6r,9r,12s,16s)-6-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
(1s,6s,9r,12s,16r)-6-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
(3r,7e)-12,14-dihydroxy-3-methyl-4,5,6,10-tetrahydro-3h-2-benzoxacyclododecine-1,9-dione
(3s,5s)-3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one
3-(2h-1,3-benzodioxol-5-ylmethyl)-6-isopropyl-3,6-dihydropyrazine-2,5-diol
5-(2,5-dihydroxyphenyl)-3-(5-hydroxy-4-methylpent-3-en-1-yl)-5h-furan-2-one
4,5-dimethoxy-3-(2-oxo-4-phenylbutyl)-5h-furan-2-one
[(2s)-7-hydroxy-4-oxo-2-[(1e)-pent-1-en-1-yl]-2,3-dihydro-1-benzopyran-5-yl]acetic acid
(1s,9r,12r,13r)-13-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
(5e,8r)-5-ethylidene-8,12-dihydroxy-13-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one
(1s,9r,12s,15r)-15-hydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2,7-diene-4,11-dione
7-hydroxy-6,8-dimethoxy-3-(2-methylbut-3-en-2-yl)chromen-2-one
8-[(1s,2r)-2-hydroxy-1-methoxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
6-methoxy-3,15-dimethyl-5,14-dioxatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-2,11-diene-4,13-dione
5-hydroxy-8-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-7-methoxy-2-methylchromen-4-one
9-methoxy-4,12,12-trimethyl-5,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2(7),8-triene-6,14-dione
methyl (3as,11ar)-10-formyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
5-ethyl-8,11-dihydroxy-12-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one
5,7-dimethoxy-8-(3-methyl-2-oxobutyl)chromen-2-one
8-hydroxy-6,7-dimethoxy-3-(2-methylbut-3-en-2-yl)chromen-2-one
6,8-dimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-2-one
(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl (4r)-2-methyl-3,4,5,6-tetrahydropyrimidine-4-carboperoxoate
C11H18N2O7 (290.11139579999997)